HUMACYTE INC shareholders Q3 2023

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
BROWN ADVISORY INC 13,129$38,4680.00%
Invesco Ltd. 23,644$69,2770.00%
AMALGAMATED BANK 8,597$250.00%
WOLVERINE TRADING, LLC 10,200$29,8860.00%
WOLVERINE TRADING, LLC 11,861$34,7530.00%
ProShare Advisors LLC 14,717$43,1210.00%
BlackRock Inc. 4,500,486$13,186,4220.00%
Bank of New York Mellon Corp 264,408$774,7160.00%
Citadel Advisors 1,500$4,3950.00%
Nuveen Asset Management, LLC 81,778$239,6100.00%
Citadel Advisors 278,587$816,2600.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 22,600$66,2180.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 75,433$221,0190.00%
Daiwa Securities Group Inc. 301$10.00%
SIMPLEX TRADING, LLC 10,241$300.00%
Citadel Advisors 63,000$184,5900.00%
Tower Research Capital LLC (TRC) 2,485$7,2810.00%
Allspring Global Investments Holdings, LLC 3,885$11,3830.00%
JPMORGAN CHASE & CO 61,595$180,4740.00%
BARCLAYS PLC 23,788$700.00%

This page lists HUMACYTE INC's shareholders in Q3 2023. To view HUMACYTE INC's shareholder history, click here.